Influence of the thyroid remnant in the elevation of the serum thyroglobulin after thyroidectomy in differentiated thyroid carcinoma. Importance of the diagnostic iodine total-body scanning

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 8, 2008, Pages 1449-1456

  Caballero Calabuig, Elisa ^a   Cano Terol, Carmen ^a   Sopena Monforte, Ramón ^a   Reyes Ojeda, Dolores ^a   Abreu Sánchez, Pedro ^a   Ferrer Rebolleda, José ^a   Sopena Novales, Pablo ^a   Plancha Mansanet, Carmen ^a   Félix Fontestad, Jesús ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Differentiated thyroid carcinoma; Radioiodine 131; Thyroglobulin; Whole body scan

Indexed keywords

IODINE 131; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID GLAND; THYROIDECTOMY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ARTIFACTS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; WHOLE BODY IMAGING;

EID: 48149106756     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0789-y     Document Type: Article

References (25)

1. EL Mazzaferri RT Kloos 2001 Current approaches to primary therapy for papillary and follicular thyroid cancer J Clin Endocrinol Metab 86 4 1447 63
2. National Comprehensive Cancer Network (NCCN). Thyroid carcinoma. Clinical practice guidelines in oncology, version 1. Fort Washington: NCCN; 2005.
3. 131I for the treatment of differentiated thyroid carcinoma J Nucl Med 46S 28S 37S
4. M Schlumberger G Berg O Cohen L Duntas F Jamar B Jarzab 2004 Follow up of low-risk patients with differentiated thyroid carcinoma: an European Perspective Eur J Endocrinol 150 105 12
5. EL Mazzaferri RJ Robbins CA Spencer LE Braverman F Pacini L Wartofsky 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma J Clin Endocrinol Metab 88 1433 41
6. F Pacini E Molinaro MG Castagna L Agate R Elisei F Ceccarelli 2003 Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma J Clin Endocrinol Metab 88 3668 73
7. Freitas JE. Changing concepts in the management of thyroid cancer. In: Freeman LM, editor. Nuclear Medicine Annual 2003. Philadelphia: Lippincott Williams and Wilkins; 2003. p. 101-29.
8. 131I whole-body scanning results? J Nucl Med 46 1164 70
9. M Ozata S Suzuki T Miyamoto R Tsuan liu F Fierro-Renoy L Degroot 1994 Serum thyroglobulin in the follow up of patients with treated differentiated thyroid cancer J Clin Endocrinol Metab 79 98 105
10. 131I for remnant ablation in patients with differentiated thyroid carcinoma Cancer 77 2574 80
11. AM Samuel B Rajashekharrao 1994 Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery J Nucl Med 35 1944 50
12. F Pacini PW Ladenson M Schlumberger A Driedger M Luster RT Kloos 2006 Radioiodine ablation of thyroid remnants after preparation with recombinant thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study J Clin Endocrinol Metab 91 3 926 32
13. 131Iodine J Nucl Med 43 856 61
14. MD Abós Olivares P González 2005 Controversias en el seguimiento del carcinoma diferenciado de tiroides. Nuevas respuestas a viejas cuestiones Rev Esp Med Nucl 24 3 207 15
15. 131I whole-body scanning J Nucl Med 46 9 1473 80
16. AM Sawka K Thephamongkhol M Brouwers L Thabane G Browman HC Gerstein 2004 A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer J Clin Endocrinol Metab 89 3668 76
17. AJ Brendel B Lambert M Guyot R Jeandot H Dubourg P Roger 1990 Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma Eur J Nucl Med 16 35 8
18. MJ Schlumberger 1998 Papillary and follicular thyroid carcinoma N Engl J Med 338 5 297 306
19. DL Bushnell MA Boles GE Kaufman MA Wadas WE Barnes 1992 Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma J Nucl Med 33 2214 21
20. L Wartofsky SI Sherman J Gopal M Schlumberger ID Hay 1998 The use of radioactive iodine in patients with papillary and follicular thyroid cancer J Clin Endocrinol and Metab 83 12 4195 203
21. ID Hay GG Klee 1993 Thyroid cancer diagnosis and management Clin Lab Med 13 3 725 34
22. ID Hay GB Thompson CS Grant EJ Bergstralh CE Dvorak CA Gorman 2002 Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutive treated patients World J Surg 26 879 85
23. L Pace M Klain C Albanese B Salvatore G Storto A Soricelli 2006 Short term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment Eur J Nucl Med Mol Imaging 33 179 83
24. 131I activities versus untreated patients J Clin Endocrinol Metab 86 4092 97
25. F Pacini M Schlumberger H Dralle R Elisei JWA Smit W Wiersinga 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Eur J Endocrinol 154 787 803